Actualités
Séminaires

Virginie Georget

MRI, BioCampus Montpellier, UAR 3426 CNRS - US 09 INSERM - UM

“Montpellier Ressources Imagerie: our offer, what's new, future prospects“

“Plateforme MRI, nos offres, les nouveautés et notre évolution“

contact: alexandre.djiane@inserm.fr

Patrick Jouandin

Dept of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Ms., USA

Regulation of Growth during nutrient limitation

contact: alexandre.djiane@inserm.fr

Séminaire en distanciel, un lien Zoom sera diffusé la semaine précédente 

Patrick Jouandin

Dept of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Ms., USA

Regulation of Growth during nutrient limitation

contact: alexandre.djiane@inserm.fr

Séminaire en distanciel, un lien Zoom sera diffusé la semaine précédente 

Julien Marie

CRCL, INSERM U1052/CNRS UMR 5286, Centre Léon Bérard, Université Lyon 1

"Cooperation between Cancer cells and Tregs  to create a potent Immunosuppressive  micro-environment in tumors."

contact: nathalie.bonnefoy@inserm.fr

Julien Marie

CRCL, INSERM U1052/CNRS UMR 5286, Centre Léon Bérard, Université Lyon 1

"Cooperation between Cancer cells and Tregs  to create a potent Immunosuppressive  micro-environment in tumors."

contact: nathalie.bonnefoy@inserm.fr

Marie-Caroline Dieu-Nosjean

Immune Microenvironment and Immunotherapy Lab, UMR1135 Inserm, Hopital Pitié-Salpêtriere, Paris.

"Tertiary lymphoid structures: an anti-tumor school for adaptive immune cells and an antibody factory to fight cancer "

contact: nathalie.bonnefoy@inserm.fr

Marie-Caroline Dieu-Nosjean

Immune Microenvironment and Immunotherapy Lab, UMR1135 Inserm, Hopital Pitié-Salpêtriere, Paris.

"Tertiary lymphoid structures: an anti-tumor school for adaptive immune cells and an antibody factory to fight cancer "

contact: nathalie.bonnefoy@inserm.fr

Olivier de Wever 

University of Gent, Experimental Cancer Research Lab, Belgium

“From spheroids to extracellular vesicles: finding unknown unknowns to create minimum information guidelines and advance biological understanding”

Contact: jean-pierre.pouget@inserm.fr

Some more on the speaker:

Since his PhD, he has been working on cancer-associated fibroblasts (CAFs) in colon cancer progression (De Wever et al., FASEBJ 2004, J Pathol 2003, J Cell Science 2004 over 1000 cumulative WOS citations). I He expanded his research into adipose tissue during his post-doc (Lapeire et al., Cancer Res 2014) and the secretory mechanisms of pro-metastatic signals (Hendrix et al., JNCI 2010, Cancer Res 2010). His current lab woks on tumor-environment interactions  including design of model systems (De Jaeghere et al., Biomaterials 2018), response to therapy of CAFs (Tommelein et al., Cancer Res 2018), and exploitation of CAFs as therapy (De Vlieghere et al., Biomaterials 2015) and extracellular vesicles with the Hendrix lab (De Wever and Hendrix EMBOJ 2019).